EMTEK(SZ:300938)2023-04-03 16:00Financial Performance - The company's operating revenue for 2022 was RMB 545,108,653.48, representing a 38.11% increase compared to RMB 394,704,752.61 in 2021[25]. - The net profit attributable to shareholders for 2022 was RMB 118,048,837.87, up 47.46% from RMB 80,055,681.76 in the previous year[25]. - The net profit after deducting non-recurring gains and losses was RMB 106,340,068.69, reflecting a 58.89% increase from RMB 66,928,326.35 in 2021[25]. - The net cash flow from operating activities reached RMB 173,531,739.54, a significant increase of 70.46% compared to RMB 101,799,333.29 in 2021[25]. - The total assets at the end of 2022 amounted to RMB 1,471,901,040.15, which is a 10.49% increase from RMB 1,332,120,549.85 at the end of 2021[25]. - The net assets attributable to shareholders increased to RMB 1,126,464,922.97, marking an 11.01% rise from RMB 1,014,722,940.92 in the previous year[25]. - The basic earnings per share for 2022 was RMB 1.0625, up 43.81% from RMB 0.7388 in 2021[25]. - The diluted earnings per share was RMB 1.0548, representing a 42.77% increase from RMB 0.7388 in the previous year[25]. - The weighted average return on equity for 2022 was 11.03%, an increase of 2.49 percentage points from 8.54% in 2021[25]. - The company reported a total revenue of 1,024 million in 2021, showing a significant increase from 470.2 million in 2019, representing a growth of approximately 117.1%[169]. - The company reported a significant increase in revenue, achieving a total of 1.5 billion RMB for the fiscal year, representing a 20% year-over-year growth[174]. Dividend and Profit Distribution - The company plans to distribute a cash dividend of 3 RMB per 10 shares to all shareholders, based on a total of 113,790,200 shares[4]. - The board of directors has approved a profit distribution plan, with no bonus shares to be issued[4]. - The board of directors has approved a dividend payout of 0.5 RMB per share, reflecting a commitment to returning value to shareholders[174]. Risk Management and Strategic Development - The company emphasizes the importance of risk awareness regarding future strategic developments and projections[4]. - The management discussion section outlines potential risks and countermeasures for future development[4]. Market and Industry Insights - The Chinese inspection and testing market size reached ¥4,090 billion in 2021, growing by ¥504 billion or 14.05% compared to 2020[40]. - The number of inspection reports issued by Chinese testing institutions reached 684 million in 2021, reflecting a year-on-year growth of 20.58%[42]. - The number of testing institutions in China increased to 51,949 by the end of 2021, representing a growth of 6.19%[42]. - The revenue of scale above testing institutions in 2021 was ¥3,228.30 billion, with a year-on-year increase of 16.37%[43]. - The global inspection and testing market is projected to maintain a compound annual growth rate of over 9%[38]. Research and Development - The company holds 281 patents, significantly higher than the industry average of 1.78 patents per institution[49]. - The company has established 8 laboratories in major cities, enhancing its service radius and efficiency[49]. - The company is currently developing a human weight static load testing machine, aiming to achieve a practical new patent to enhance testing quality and efficiency[103]. - The company is developing a wedge-shaped probe device for measuring mechanical hazards in shredders, aiming to enhance testing quality and efficiency[106]. - The company has completed the development of several new products, including a lithium battery explosion-proof device and a pneumatic wedge device, enhancing market competitiveness[110]. - The number of R&D personnel increased by 13.40% from 194 in 2021 to 220 in 2022, with R&D personnel accounting for 15.55% of the total workforce[111]. - R&D investment amounted to ¥47,775,078.41 in 2022, representing 8.76% of operating revenue, an increase from 7.89% in 2021[111]. Operational Efficiency and Cost Management - The company has successfully reduced operational costs by 5% through improved supply chain management practices[182]. - The company aims to launch three new products in 2023, which are anticipated to contribute an additional 200 million RMB in revenue[188]. - The company has set a target to reduce operational costs by 15% through digital transformation initiatives[188]. Governance and Compliance - The company maintained a robust governance structure, holding 13 board meetings and 12 supervisory meetings in 2022, ensuring compliance with regulations[152][154]. - The company reported a complete independence in assets, personnel, finance, and operations from its controlling shareholders, ensuring a fully operational business system[159]. - The company strictly followed information disclosure regulations, ensuring timely and accurate communication of significant operational matters[156]. - The company has established a comprehensive internal control system to enhance governance and operational efficiency[149]. Future Outlook and Strategic Goals - The company provided a positive outlook for 2023, projecting a revenue growth of 25% based on new product launches and market expansion strategies[188]. - The company plans to expand its market presence in Southeast Asia, targeting a 10% market share by 2025[188]. - The company aims to achieve a break-even point in new business areas such as health and environmental testing while ensuring the successful implementation of annual targets[137]. - The company will continue to optimize its service network and expand production capacity, particularly through the construction of the Central China dual-use testing base and projects in the new energy vehicle sector[140].